Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis

Gut Dysbiosis Associated With Hepatitis C Virus Infection

(2018) Takako Inoue et al.   CLINICAL INFECTIOUS DISEASES

Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus

(2018) Michael Reid et al.   JOURNAL OF INFECTIOUS DISEASES

Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France

(2018) A. Cousien et al.   JOURNAL OF VIRAL HEPATITIS

Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia

(2017) Ekaterine Dolmazashvili et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Improvement of liver stiffness in patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response

(2017) Toshifumi Tada et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Targeting the gut-liver axis in liver disease

(2017) Reiner Wiest et al.   JOURNAL OF HEPATOLOGY

Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients

(2017) N. Merchante et al.   JOURNAL OF VIRAL HEPATITIS

Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients

(2017) Jean-Jacques Tudesq et al.   PLoS One

Monocyte chemoattractant protein 1 released from macrophages induced by hepatitis C virus promotes monocytes migration

(2017) Yuan Liu et al.   VIRUS RESEARCH

Hepatitis C virus infection

(2017) Michael P. Manns et al.   Nature Reviews Disease Primers

Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon

(2017) Claudia Mascia et al.   PLoS One

HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients

(2016) J. S. Bajaj et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Statistical evaluation of methods for identification of differentially abundant genes in comparative metagenomics

(2016) Viktor Jonsson et al.   BMC GENOMICS

Association of immune response parameters with virological response in hepatitis C virus patients treated with pegylated consensus interferon

(2016) Yanhua Ding et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy

(2016) V. Knop et al.   JOURNAL OF VIRAL HEPATITIS

Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index

(2016) Jacqueline A. Bachofner et al.   LIVER INTERNATIONAL

Gut microbiome alterations in patients with stage 4 hepatitis C

(2016) AbdelRahman Mahmoud Aly et al.   Gut Pathogens

The correlation between pretreatment cytokine expression patterns in peripheral blood mononuclear cells with chronic hepatitis c outcome

(2015) Joanna Jabłońska et al.   BMC INFECTIOUS DISEASES

Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection

(2015) Paolo Sacchi et al.   DIGESTIVE AND LIVER DISEASE

Gut Microbiota, Cirrhosis, and Alcohol Regulate Bile Acid Metabolism in the Gut

(2015) Jason M. Ridlon et al.   DIGESTIVE DISEASES

Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection

(2015) Aaron F. Carlin et al.   HEPATOLOGY

Roles for Chemokines in Liver Disease

(2014) Fabio Marra et al.   GASTROENTEROLOGY

Hepatitis C Virus-Specific Th17 Cells Are Suppressed by Virus-Induced TGF- 

(2014) A. G. Rowan et al.   JOURNAL OF IMMUNOLOGY

Alterations of the human gut microbiome in liver cirrhosis

(2014) Nan Qin et al.   NATURE

Modulation of the fecal bile acid profile by gut microbiota in cirrhosis

(2013) Genta Kakiyama et al.   JOURNAL OF HEPATOLOGY

Altered profile of human gut microbiome is associated with cirrhosis and its complications

(2013) Jasmohan S. Bajaj et al.   JOURNAL OF HEPATOLOGY

Galectin-9 and IL-21 Mediate Cross-regulation between Th17 and Treg Cells during Acute Hepatitis C

(2013) Hassen Kared et al.   PLoS Pathogens

Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection

(2012) Gabriel M. Sousa et al.   CYTOKINE

A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis

(2012) Roberta D'Ambrosio et al.   HEPATOLOGY

Host Response to Translocated Microbial Products Predicts Outcomes of Patients With HBV or HCV Infection

(2011) Netanya G. Sandler et al.   GASTROENTEROLOGY

Characterization of fecal microbial communities in patients with liver cirrhosis

(2011) Yanfei Chen et al.   HEPATOLOGY